The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
Imaging of Neuroendocrine Tumors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Reubi, J. C., Schär, J.-C., Waser, B., Wenger, S., Heppeler, A., Schmitt, J. S., & Mäcke, H. R. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050034 · Cited by 1,127
Ilias, I., Torpy, D. J., Pacak, K., Mullen, N., Wesley, R. A., & Nieman, L. K. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2527 · Cited by 713
Kebebew, E., Ituarte, P. H. G., Siperstein, A. E., Duh, Q.-Y., & Clark, O. H. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000301)88:5<1139::aid-cncr26>3.0.co;2-z · Cited by 684
The diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674
Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma
Pacak, K., Linehan, W. M., Eisenhofer, G., Walther, M. M., & Goldstein, D. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-4-200102200-00016 · Cited by 618
Reubi, J. C., & Waser, B. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1184-3 · Cited by 592
Öberg, K., Kvols, L., Caplin, M., Delle Fave, G., de Herder, W., Rindi, G., Ruszniewski, P., Woltering, E. A., & Wiedenmann, B. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh216 · Cited by 577
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
Isidori, A. M., Kaltsas, G. A., Pozza, C., Frajese, V., Newell-Price, J., Reznek, R. H., Jenkins, P. J., Monson, J. P., Grossman, A. B., & Besser, G. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1542 · Cited by 522
Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., et al. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc/2002.31025 · Cited by 435
Yttrium-90 DOTATOC: first clinical results
Otte, A., Herrmann, R., Heppeler, A., Behe, M., Jermann, E., Powell, P., Maecke, H. R., & Muller, J. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050476 · Cited by 420
Adams, S., Baum, R., Rink, T., Schumm-Dräger, P.-M., Usadel, K.-H., & Hör, G. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050197 · Cited by 387
Self-citationReske, S. N., & Kotzerke, J. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100626 · Cited by 365
Eisenhofer, G. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00144-9 · Cited by 342
Orlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
Pheochromocytomas: Detection with18F DOPA Whole-Body PET—Initial Results
Hoegerle, S., Nitzsche, E., Altehoefer, C., Ghanem, N., Manz, T., Brink, I., Reincke, M., Moser, E., & Neumann, H. P. H. (2002) · Radiology · doi:10.1148/radiol.2222010622 · Cited by 325
Wild, D., Schmitt, J. S., Ginj, M., Mäcke, H. R., Bernard, B. F., Krenning, E., de Jong, M., Wenger, S., & Reubi, J.-C. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1255-5 · Cited by 310
Caplin, M. E., Buscombe, J. R., Hilson, A. J., Jones, A. L., Watkinson, A. F., & Burroughs, A. K. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02286-7 · Cited by 309
Pheochromocytomas: Imaging with 2-[Fluorine-18]fluoro-2-deoxy-d-glucose PET
Shulkin, B. L., Thompson, N. W., Shapiro, B., Francis, I. R., & Sisson, J. C. (1999) · Radiology · doi:10.1148/radiology.212.1.r99jl3035 · Cited by 305
Kowalski, J. (2003) · Molecular Imaging & Biology · doi:10.1016/s1536-1632(03)00038-6 · Cited by 304
Kaltsas, G. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.895 · Cited by 275
Whole-Body18F Dopa PET for Detection of Gastrointestinal Carcinoid Tumors
Hoegerle, S., Altehoefer, C., Ghanem, N., Koehler, G., Waller, C. F., Scheruebl, H., Moser, E., & Nitzsche, E. (2001) · Radiology · doi:10.1148/radiology.220.2.r01au25373 · Cited by 269
Virgolini, I., Raderer, M., Kurtaran, A., Angelberger, P., Banyai, S., Yang, Q., Li, S., Banyai, M., Pidlich, J., Niederle, B., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199410273311703 · Cited by 257
Kwekkeboom, D. J., & Krenning, E. P. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31022 · Cited by 252
Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography.
Schwaiger, M., Kalff, V, Rosenspire, K., Haka, M. S., Molina, E., Hutchins, G. D., Deeb, M., Wolfe, E., & Wieland, D. M. (1990) · Circulation · doi:10.1161/01.cir.82.2.457 · Cited by 242
Ilias, I., Yu, J., Carrasquillo, J. A., Chen, C. C., Eisenhofer, G., Whatley, M., McElroy, B., & Pacak, K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030235 · Cited by 241
Hoegerle, S., Altehoefer, C., Ghanem, N., Brink, I., Moser, E., & Nitzsche, E. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590000404 · Cited by 233
Pacak, K., Eisenhofer, G., Carrasquillo, J. A., Chen, C. C., Li, S.-T., & Goldstein, D. S. (2001) · Hypertension · doi:10.1161/01.hyp.38.1.6 · Cited by 216
Termanini, B., Gibril, F., Reynolds, J., Doppman, J., Chen, C., Stewart, C., Sutliff, V., & Jensen, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9024287 · Cited by 206
Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide
Paganelli, G., Zoboli, S., Cremonesi, M., Bodei, L., Ferrari, M., Grana, C., Bartolomei, M., Orsi, F., De Cicco, C., Mäcke, H. R., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100490 · Cited by 206
[99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging
Nock, B., Nikolopoulou, A., Chiotellis, E., Loudos, G., Maintas, D., Reubi, J., & Maina, T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1040-x · Cited by 194
Wild, D., Mäcke, H. R., Waser, B., Reubi, J. C., Ginj, M., Rasch, H., Müller-Brand, J., & Hofmann, M. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1697-4 · Cited by 192
SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours
Krausz, Y., Keidar, Z., Kogan, I., Even‐Sapir, E., Bar‐Shalom, R., Engel, A., Rubinstein, R., Sachs, J., Bocher, M., Agranovicz, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01885.x · Cited by 192
H., W., M., S., K., S., G., M., M., H., F., R., J., R., & M., S. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1012-1 · Cited by 177
Shin, H. J. C., Lahoti, S., & Sneige, N. (2002) · Cancer · doi:10.1002/cncr.10614 · Cited by 172
Chiti, A., Fanti, S., Savelli, G., Romeo, A., Bellanova, B., Rodari, M., van Graafeiland, B. J., Monetti, N., & Bombardieri, E. (1998) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050314 · Cited by 168
Pasquali, C., Rubello, D., Sperti, C., Gasparoni, P., Liessi, G., Chierichetti, F., Ferlin, G., & Pedrazzoli, S. (1998) · World Journal of Surgery · doi:10.1007/s002689900439 · Cited by 162
Diehl, M., Risse, J. H., Brandt-Mainz, K., et al. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100614 · Cited by 155
Wafelman, A. R., Hoefnagel, C. A., Maes, R. A. A., & Beijnen, J. (1994) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00173043 · Cited by 155
High expression of peptide receptors as a novel target in gastrointestinal stromal tumours
Reubi, J. C., K�rner, M., Waser, B., Mazzucchelli, L., & Guillou, L. (2004) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1476-2 · Cited by 154
Jalil, N. D., Pattou, F. N., Combemale, F., Chapuis, Y., Henry, J., Peix, J., & Proye, C. A. G. (2002) · The European Journal of Surgery · doi:10.1080/110241598750004913 · Cited by 153
Somatostatin and Other Peptide Receptors as Tools for Tumor Diagnosis and Treatment
Reubi, J. C. (2004) · Neuroendocrinology · doi:10.1159/000080742 · Cited by 152
Imaging of pheochromocytoma and paraganglioma
Brink, I., Hoegerle, S., Klisch, J., & Bley, T. A. (2005) · Familial Cancer · doi:10.1007/s10689-004-2155-y · Cited by 152
Behr, T. M., & Béhé, M. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2002.31028 · Cited by 149
Positron emission tomography with 5-hydroxytryprophan in neuroendocrine tumors.
Örlefors, H., Sundín, A., Ahlström, H. K., Bjurling, P., Bergström, M., Lilja, A., Långström, B., Öberg, K., & Eriksson, B. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2534 · Cited by 147
Hybrid SPECT/CT: a new era for SPECT imaging?
Schillaci, O. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1760-9 · Cited by 147
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
Kaltsas, G., Papadogias, D., Makras, P., & Grossman, A. B. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01116 · Cited by 145
Pacák, K., Ilias, Ι., Chen, C. C., Carrasquillo, J. A., Whatley, M. A., & Nieman, L. K. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031812 · Cited by 136
[123I]Metaiodobenzylguanidine and [111In]Octreotide Uptake in Benign and Malignant Pheochromocytomas
van der Harst, E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.2.685 · Cited by 131
de Groot, J. W. B., Links, T. P., Jager, P. L., et al. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.10.015 · Cited by 130
Differences between sporadic and multiple endocrine neoplasia type 2A phaeochromocytoma
Pomares, F. J., Canas, R., Rodriguez, J. M., Hernandez, A. M., Parrilla, P., & Tebar, F. J. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3751208.x · Cited by 124
Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours
Öberg, K., & Eriksson, B. K. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.016 · Cited by 116
Detecting Pheochromocytoma: Defining the Most Sensitive Test
Güller, U., Turek, J., Eubanks, S., DeLong, E. R., Oertli, D., & Feldman, J. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000193833.51108.24 · Cited by 115
Furuta, N., Kiyota, H., Yoshigoe, F., Hasegawa, N., & Ohishi, Y. (1999) · International Journal of Urology · doi:10.1046/j.1442-2042.1999.06310.x · Cited by 114
Tabarin, A., Valli, N., Chanson, P., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.4.5583 · Cited by 113
The Role of PET in Localization of Neuroendocrine and Adrenocortical Tumors
Eriksson, B. K., Bergström, M., Sundin, A., Juhlin, C., Örlefors, H., Öberg, K., & Långström, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04422.x · Cited by 109
Gotthardt, M., Fischer, M., Naeher, I., Holz, J. B., Jungclas, H., Fritsch, H., Béhé, M. P., Göke, B., Joseph, K., & Behr, T. M. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0761-1 · Cited by 106
Ginj, M., Chen, J., Walter, M. A., Eltschinger, V., Reubi, J. C., & Maëcke, H. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1136.11.3 · Cited by 101
Neuroendocrine gastrointestinal tumours
Öberg, K. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010633 · Cited by 100
Brandt-Mainz, K., Müller, S. P., Görges, R., et al. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050533 · Cited by 99
Katzenstein, H. M., Cohn, S. L., Shore, R. M., Bardo, D. M. E., Haut, P. R., Olszewski, M., Schmoldt, J., Liu, D., RADEMAKER, A. W., & Kletzel, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.144 · Cited by 95
Treatment of medullary thyroid carcinoma: an update.
Orlandi, F., Caraci, P., Mussa, A., Saggiorato, E., Pancani, G., & Angeli, A. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080135 · Cited by 94
FDG-PET: procedure guidelines for tumour imaging
Bombardieri, E., Aktolun, C., Baum, R. P., Bishof-Delaloye, A., Buscombe, J. R., Chatal, J. F., Maffioli, L. S., Moncayo, R., Mortelmans, L., & Reske, S. N. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1355-2 · Cited by 94
Self-citationMamede, M. H., Carrasquillo, J. A., Chen, C. C., Corral, P. D., Whatley, M. A., Ilias, Ι., Ayala, A., & Pacák, K. (2005) · Nuclear Medicine Communications · doi:10.1097/01.mnm.0000189780.54658.e8 · Cited by 93
Developments in PET for the detection of endocrine tumours
Eriksson, B., Örlefors, H., Öberg, K., Sundín, A., Bergström, M., & Långström, B. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2004.11.001 · Cited by 93
Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
Bossche, B. V. D., & de Wiele, C. V. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.216 · Cited by 91
Jensen, R. T. (2000) · Current Opinion in Oncology · doi:10.1097/00001622-200007000-00015 · Cited by 84
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma
Abdelmoumene, N., Schlumberger, M. J., Gardet, P., Roche, A., Travagli, J. P., Francese, C., & Parmentier, C. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.224 · Cited by 79
Radioisotope diagnosis and therapy of malignant pheochromocytoma
Shapiro, B., Gross, M. D., & Shulkin, B. L. (2001) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(01)00492-1 · Cited by 74
Berglund, A. S., Hulthén, U. L., Manhem, P., Thorsson, O., Wollmer, P., & Törnquist, C. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00792.x · Cited by 71
Pretargeting using peptide nucleic acid
Rusckowski, M., Qu, T., Chang, F., & Hnatowich, D. J. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19971215)80:12+<2436::aid-cncr16>3.0.co;2-d · Cited by 63
Visualization of the thymus by substance P receptor scintigraphy in man
van Hagen, P. M., Breeman, W. A. P., Reubi, J. C., Postema, P. T., van den Anker-Lugtenburg, P. J., Kwekkeboom, D. J., Laissue, J. A., Waser, B., Lamberts, S. W. J., Visser, T. J., et al. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01254476 · Cited by 56
Chromogranin A assay and (131)I-MIBG scintigraphy for diagnosis and follow-up of pheochromocytoma.
d’Herbomez, M., Gouze, V., Huglo, D. G., Calzada-Nocaudie, M., Pattou, F. N., Proye, C. A. G., Wémeau, J.-L., & Marchandise, X. (2001) · PubMed · Cited by 56
Gotthardt, M., Battmann, A., H�ffken, H., Schurrat, T., Pollum, H., Beuter, D., Gratz, S., h, M. B., Bauhofer, A., KLOSE, K. J., et al. (2004) · Nuclear Medicine Communications · doi:10.1097/00006231-200405000-00003 · Cited by 54
Hessenius, C., Bäder, M., MEINHOLD, H., Böhmig, M., Faiss, S., Reubi, J., & Wiedenmann, B. J. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000325 · Cited by 53
Medullary carcinoma of the thyroid: Current diagnosis and management
Lairmore, T. C., & Wells, S. A. (1991) · Seminars in Surgical Oncology · doi:10.1002/ssu.2980070209 · Cited by 52
Sundin, A., Eriksson, B. K., Bergström, M., Bjurling, P., Lindner, K., Öberg, K., & Långström, B. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00085-2 · Cited by 47
Taïeb, D., Sebag, F. A., Hubbard, J., MUNDLER, O., Henry, J.-F., & Conte‐Devolx, B. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02077.x · Cited by 47
Functional–Anatomical Image Fusion in Neuroendocrine Tumors
Schillaci, O. (2004) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497804773391775 · Cited by 44
Isidori, A. M., Kaltsas, G., Frajese, V., Kola, B., Whitelocke, R. A. F., Plowman, P. N., Britton, K. E., Monson, J. P., Grossman, A. B., & BESSER, G. M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.4.8407 · Cited by 44
Intraoperative tumour detection using 111 In-DTPA- D -Phe 1 -octreotide and a scintillation detector
Benjegård, S. A., Forssell-Aronsson, E. B., Wängberg, B., Skånberg, J., Nilsson, O., & Ahlman, H. (2001) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590100600 · Cited by 35
Gelfand, M. J. (2004) · Pediatric Radiology · doi:10.1007/s00247-003-1136-x · Cited by 30
New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.
Virgolini, I. J., Traub, T., Leimer, M., Novotny, C., Pangerl, T., Ofluoglu, S., Halvadjieva, E., Smith-Jones, P. M., Flores, J., Li, S., et al. (2000) · PubMed · Cited by 28
Siccardi, A. G., Paganelli, G., Pontiroli, A. E., Pelagi, M., Magnani, P., Viale, G., Faglia, G., & Fazio, F. (1996) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf01254467 · Cited by 27
99m Tc-EDDA/HYNIC-TOC in the Management of Medullary Thyroid Carcinoma
Parisella, M. G., D’Alessandria, C., Bossche, B. V. D., Chianelli, M., Ronga, G., Papini, E., Mikołajczak, R., Letizia, C., Toma, G. D., Veneziani, A., et al. (2004) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497804323071995 · Cited by 26
Octreoscan SPET Evaluation in the Diagnosis of Pancreas Neuroendocrine Tumors
Briganti, V., Matteini, M., Ferri, P., Vaggelli, L., Castagnoli, A., & Pieroni, C. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780152752119 · Cited by 26
123 I-MIBG scintigraphy of catecholamine systems: impediments to applications in clinical medicine
Eisenhofer, G. (2000) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590000263 · Cited by 20
Nuklearmedizinische Diagnostik neuroendokriner Tumoren
Baum, R. P., & Hofmann, M. (2004) · Der Onkologe · doi:10.1007/s00761-004-0716-1 · Cited by 11
Self-citation
Cited by
Cancer Treatment Using Peptides: Current Therapies and Future Prospects
Thundimadathil, J. (2012) · Journal of Amino Acids · doi:10.1155/2012/967347 · Cited by 491
A review on the clinical uses of SPECT/CT
Mariani, G., Bruselli, L., Kuwert, T., Kim, E. E., Flotats, A., Israel, O., Dondi, M., & Watanabe, N. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1390-8 · Cited by 438
Antunes, P., Ginj, M., Zhang, H., Waser, B., Baum, R. P., Reubi, J. C., & Maecke, H. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-006-0317-x · Cited by 393
Self-citationSadowski, S. M., Neychev, V., Millo, C., Shih, J., Nilubol, N., Herscovitch, P., Pacak, K., Marx, S. J., & Kebebew, E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0987 · Cited by 353
Peptides and Peptide Hormones for Molecular Imaging and Disease Diagnosis
Lee, S., Xie, J., & Chen, X. (2010) · Chemical Reviews · doi:10.1021/cr900361p · Cited by 324
Metadata
- Authors
- Rufini, V., Calcagni, M. L., & Baum, R. P.
- Venue
- Seminars in Nuclear Medicine
- Publisher
- Elsevier BV
- Published
- 2006-07
- Volume
- 36
- Issue
- 3
- Pages
- 228-247
- ISSN
- 0001-2998 (ISSN-L)
- OpenAlex
- W1999233004
- Cited by
- 376
- References
- 90
- FWCI
- 21.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.